Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis

OBJECTIVE: Little is known on the disease course of very early systemic sclerosis (SSc). Among the information yet to be elucidated is whether anticentromere antibody (ACA) isotype levels can serve as biomarkers for future SSc development and for organ involvement. This study was undertaken to evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: van Leeuwen, Nina M., Boonstra, Maaike, Bakker, Jaap A., Grummels, Annette, Jordan, Suzana, Liem, Sophie, Distler, Oliver, Hoffmann‐Vold, Anna‐Maria, Melsens, Karin, Smith, Vanessa, Truchetet, Marie‐Elise, Scherer, Hans U., Toes, René, Huizinga, Tom W. J., de Vries‐Bouwstra, Jeska K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Systemic Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297867/
https://www.ncbi.nlm.nih.gov/pubmed/34042326
http://dx.doi.org/10.1002/art.41814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297867/
https://www.ncbi.nlm.nih.gov/pubmed/34042326
http://dx.doi.org/10.1002/art.41814

Ejemplares similares